|
Volumn 95, Issue 7, 2001, Pages 661-669
|
Plasmodium falciparum in Kenya: High prevalence of drug-resistance-associated polymorphisms in hospital admissions with severe malaria in an epidemic area
a a a a a |
Author keywords
[No Author keywords available]
|
Indexed keywords
ALANINE;
AMODIAQUINE;
ASPARAGINE;
ASPARTIC ACID;
CHLOROQUINE;
FANSIDAR;
GLUTAMIC ACID;
GLYCINE;
MEROZOITE SURFACE PROTEIN 1;
MEROZOITE SURFACE PROTEIN 2;
QUININE;
TYROSINE;
ALLELE;
ARTICLE;
CHROMOSOME 4;
CHROMOSOME 5;
CHROMOSOME 8;
CLINICAL ARTICLE;
CONTROLLED STUDY;
DNA POLYMORPHISM;
EPIDEMIC;
GENOTYPE;
HOSPITAL ADMISSION;
HUMAN;
KENYA;
MALARIA;
MEROZOITE;
PLASMODIUM FALCIPARUM;
POINT MUTATION;
PREVALENCE;
ADOLESCENT;
ADULT;
AGED;
ANIMALS;
ANTIMALARIALS;
DISEASE OUTBREAKS;
DRUG RESISTANCE;
GENOTYPE;
HOSPITALIZATION;
HUMANS;
KENYA;
MALARIA, FALCIPARUM;
MIDDLE AGED;
PLASMODIUM FALCIPARUM;
POINT MUTATION;
POLYMERASE CHAIN REACTION;
POLYMORPHISM, GENETIC;
POLYMORPHISM, RESTRICTION FRAGMENT LENGTH;
CINCHONA PUBESCENS;
PLASMODIUM FALCIPARUM;
PROTOZOA;
|
EID: 0035198972
PISSN: 00034983
EISSN: None
Source Type: Journal
DOI: 10.1080/00034980120103234 Document Type: Article |
Times cited : (43)
|
References (33)
|